Peptide research from Dubai. Retatrutide trial data, GLP-1 landscape updates, COA audits, regulatory trackers. https://remyresearch.com/feed.xml 2026-11-02T06:40:46Z Remy Research https://remyresearch.com/ (C) 2026 Remy Research. For Research Use Only. https://remyresearch.com/favicon.svg https://remyresearch.com/icon-512.png https://remyresearch.com/research/dsip-benefits-side-effects 2026-11-02T06:40:46Z 2026-10-27T00:00:00Z Remy Research Editorial Team

DSIP peptide benefits and side effects: what delta sleep-inducing peptide studies show on deep sleep, why trials disagree, safety gaps and FDA status.

https://remyresearch.com/research/epitalon-benefits-side-effects 2026-11-02T06:40:46Z 2026-10-27T00:00:00Z Remy Research Editorial Team

Epitalon benefits and side effects: telomerase and telomere data from cell studies, mixed animal life span results, who did the research, and FDA status.

https://remyresearch.com/research/glow-peptide-benefits-side-effects 2026-11-02T06:40:46Z 2026-10-27T00:00:00Z Remy Research Editorial Team

GLOW peptide pen benefits and side effects: no study has tested the GHK-Cu, BPC-157 and TB-500 blend. What each component shows and FDA’s 2026 view.

https://remyresearch.com/research/mots-c-benefits-side-effects 2026-11-02T06:40:46Z 2026-10-27T00:00:00Z Remy Research Editorial Team

MOTS-c benefits and side effects: what mouse and human studies show on insulin sensitivity and exercise, FDA’s 2026 safety findings, and WADA status.

https://remyresearch.com/research/tb-500-benefits-side-effects 2026-11-02T06:40:46Z 2026-10-27T00:00:00Z Remy Research Editorial Team

TB 500 benefits and side effects: what animal studies show, why most data are on full thymosin beta-4, FDA’s 2026 safety review, and WADA status.

https://remyresearch.com/research/controlled-medicines-permits-uae 2026-11-02T06:40:46Z 2026-10-17T16:22:00Z Remy Research Editorial Team

UAE controlled medicines permits explained: who needs one, how to apply, documents, quantity limits, and why research peptides are not covered.

https://remyresearch.com/research/maritide-maridebart-cafraglutide-profile 2026-11-02T06:40:46Z 2026-10-13T00:00:00Z Remy Research Editorial Team

MariTide (maridebart cafraglutide): Phase 2 weight-loss data, MARITIME Phase 3 status, side effects and how it compares with tirzepatide.

https://remyresearch.com/research/glow-vs-klow-vs-wolverine 2026-11-02T06:40:46Z 2026-10-10T00:00:00Z Remy Research Editorial Team

GLOW, KLOW and Wolverine compared: what each peptide blend contains, what KPV adds, the one combination study, why GHK-Cu blends are blue, and blend COAs.

https://remyresearch.com/research/bpc-157-dubai-research-vial 2026-11-02T06:40:46Z 2026-10-07T00:00:00Z Remy Research Editorial Team

BPC-157 in Dubai: clinic vs research vial vs capsules, what the evidence covers, FDA, UAE and WADA status in 2026, AED prices and how to check a batch COA.

https://remyresearch.com/research/epitalon-pineal-peptide-research 2026-11-02T06:40:46Z 2026-10-06T00:00:00Z Remy Research Editorial Team

Epitalon (Epithalon, AEDG) research review: chemistry, Epithalamin origin, cell-culture telomerase data, animal studies, 2026 FDA status and evidence gaps.

https://remyresearch.com/research/are-peptides-legal-dubai 2026-11-02T06:40:46Z 2026-04-11T00:00:00Z Remy Research Editorial Team

Are peptides legal in the UAE and Dubai? What UAE medicine and customs rules cover, where research-use listings sit, and how to verify a supplier.

https://remyresearch.com/research/are-peptides-legal 2026-11-02T06:40:46Z 2026-03-17T00:00:00Z Remy Research Editorial Team

Are peptides legal in 2026? Australia (TGA Schedule 4), US (FDA), UAE, UK, EU, Canada compared. Research-use vs human-use distinction explained.

https://remyresearch.com/research/peptide-stability-storage-guide 2026-11-02T06:40:46Z 2026-02-26T00:00:00Z Remy Research Editorial Team

How to store peptides: most powders keep for years at −20°C, solutions up to a week at 4°C, pens 2–8°C. Plus a UAE warm-parcel checklist.

https://remyresearch.com/research/phase-3-evidence-tracker/ 2026-11-02T00:00:00Z 2026-07-30T00:00:00Z Remy Research Editorial Team

A source-led retatrutide Phase 3 tracker separating peer-reviewed results, sponsor topline releases, registered trials and pending publications.

https://remyresearch.com/research/aod-9604-dubai-research-vial 2026-11-01T21:19:10Z 2026-10-18T10:16:00Z Remy Research Editorial Team

AOD-9604 in Dubai and the UAE: what the hGH fragment is, what the obesity trials found, FDA, UAE and WADA status, AED prices and batch COA checks.

https://remyresearch.com/research/oxytocin-peptide-research 2026-11-01T21:19:10Z 2026-10-12T00:00:00Z Remy Research Editorial Team

Oxytocin research review: nonapeptide chemistry, the approved childbirth use, trust and autism results that did not hold up, obesity data, 2026 status and gaps.

https://remyresearch.com/research/vip-vasoactive-intestinal-peptide-research 2026-11-01T21:19:10Z 2026-10-12T00:00:00Z Remy Research Editorial Team

VIP (vasoactive intestinal peptide) research review: VPAC receptors, VIPoma, small lung studies, failed aviptadil COVID-19 trials, 2026 status and gaps.

https://remyresearch.com/research/retatrutide-type-2-diabetes-transcend-t2d-1 2026-11-01T21:19:10Z 2026-07-18T00:00:00Z Remy Research Editorial Team

TRANSCEND-T2D-1 results: retatrutide cut HbA1c up to 1.94 points and weight up to 15.3% at 40 weeks in type 2 diabetes (Lancet, 2026). Safety and next trials.

https://remyresearch.com/research/retatrutide-side-effects 2026-11-01T21:19:10Z 2026-07-07T00:00:00Z Remy Research Editorial Team

Retatrutide side effects in trials: mostly mild-to-moderate GI events, a dose-related heart-rate rise, and a phase 3 skin-sensitivity signal. See data by dose.

https://remyresearch.com/research/ghrh-peptides-comparison 2026-11-01T21:19:10Z 2026-05-23T00:00:00Z Remy Research Editorial Team

Best growth hormone peptides compared — tesamorelin, CJC-1295, sermorelin, ipamorelin: structure, half-life, mechanism, and what the GHRH literature shows.

https://remyresearch.com/research/retatrutide-clinical-trials-uae 2026-11-01T21:19:10Z 2026-04-11T00:00:00Z Remy Research Editorial Team

Retatrutide clinical trials UAE status, October 2026: TRIUMPH/TRANSCEND registry check, no UAE-listed sites, approval boundary, and RUO sourcing context.

https://remyresearch.com/research/saxenda-vs-ozempic-liraglutide-semaglutide 2026-11-01T21:19:10Z 2026-03-10T00:00:00Z Remy Research Editorial Team

Saxenda vs Ozempic: is liraglutide or semaglutide better for weight loss? STEP 8 results, side effects, Saxenda vs Wegovy and switching.

https://remyresearch.com/research/aleniglipron-profile 2026-11-01T18:44:53Z 2026-11-01T00:00:00Z Remy Research Editorial Team

Aleniglipron (GSBR-1290) research: published ACCESS results, the Nature Medicine correction, tolerability and the recruiting ACCOMPLISH phase 3 trials.

https://remyresearch.com/research/aicar-vs-mots-c 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

AICAR vs MOTS-c: how each activates AMPK, what mouse and human studies show, known AICAR side effects, FDA status and WADA’s S4.4.1 listing.

https://remyresearch.com/research/aod-9604-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

AOD 9604 benefits and side effects: rodent fat-metabolism studies, the failed 24-week human trial, FDA safety data and how it differs from hGH 176-191.

https://remyresearch.com/research/bacteriostatic-water-refrigeration-shelf-life 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

Does bacteriostatic water need to be refrigerated? What the US label says on storage at 20–25°C, shelf life, the 28-day rule and the benzyl alcohol warning.

https://remyresearch.com/research/bpc-157-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

BPC-157 benefits and side effects: what animal models report, the five small human studies, FDA’s 2026 safety review, and why the risks are mostly unknown.

https://remyresearch.com/research/cerebrolysin-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

Cerebrolysin benefits and side effects from trials in Alzheimer’s, vascular dementia, stroke and brain injury, Cochrane reviews, and FDA and EMA status.

https://remyresearch.com/research/cjc-1295-ipamorelin-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

CJC-1295 ipamorelin side effects and benefits: what human studies of each peptide show, FDA’s safety findings, the 2024 advisory vote, and WADA status.

https://remyresearch.com/research/dihexa-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

Dihexa benefits and side effects: animal data on memory and brain injury, the retracted HGF/c-Met paper, no human trials, cancer concern, FDA status and Semax.

https://remyresearch.com/research/ghk-cu-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

GHK-Cu side effects and benefits: what topical copper peptide trials and lab studies report, why injectable GHK-Cu has no human data, and its FDA status.

https://remyresearch.com/research/igf-1-lr3-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

IGF-1 LR3 side effects and benefits: what cell and animal studies found, why no human trials exist, IGF-1 class label warnings, and its FDA and WADA status.

https://remyresearch.com/research/ipamorelin-benefits-side-effects 2026-11-01T18:44:53Z 2026-10-27T00:00:00Z Remy Research Editorial Team

Ipamorelin side effects and benefits: what animal and human studies show, the negative surgical trial, FDA’s Category 2 safety concerns, and WADA status.